Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. / (Record no. 1330)

MARC details
000 -LEADER
fixed length control field 04927naa a22006257i 4500
001 - CONTROL NUMBER
control field UMUN-OA-20261005-PH-058
003 - CONTROL NUMBER IDENTIFIER
control field local
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20261005174916.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr||||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 261005s2022 xx o u000 0 eng d
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.eclinm.2022.101624
Source of number or code doi
035 ## - SYSTEM CONTROL NUMBER
System control number (local)EuropePMC:PMC9417563
040 ## - CATALOGING SOURCE
Original cataloging agency local
Language of cataloging eng
Transcribing agency local
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
100 0# - MAIN ENTRY--PERSONAL NAME
Personal name Kin Israel Notarte
Relator term author.
245 10 - TITLE STATEMENT
Title Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. /
Statement of responsibility, etc. Kin Israel Notarte; Jesus Alfonso Catahay; Jacqueline Veronica Velasco [and others].
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture [Place of publication not identified] :
Name of producer, publisher, distributor, manufacturer Elsevier,
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (1 article).
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
500 ## - GENERAL NOTE
General note The source lists 13 contributors; the first 12 names are recorded as access points. The complete source author list is retained in the catalogue manifest.
500 ## - GENERAL NOTE
General note Publication type: Journal article.
500 ## - GENERAL NOTE
General note Linked open-access copy: published version.
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open access; no subscription required for the linked open-access version.
Standardized terminology for access restriction Unrestricted online access
Source of term star
520 3# - SUMMARY, ETC.
Summary, etc. Background Although COVID-19 vaccination decreases the risk of severe illness, it is unclear whether vaccine administration may impact the prevalence of long-COVID. The aim of this systematic review is to investigate the association between COVID-19 vaccination and long-COVID symptomatology. Methods MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to June 20, 2022. Peer-reviewed studies or preprints monitoring multiple symptoms appearing after acute SARS-CoV-2 infection either before or after COVID-19 vaccination collected by personal, telephone or electronic interviews were included. The methodological quality of the studies was assessed using the Newcastle-Ottawa Scale. Findings From 2584 studies identified, 11 peer-reviewed studies and six preprints were included. The methodological quality of 82% ( n =14/17) studies was high. Six studies ( n =17,256,654 individuals) investigated the impact of vaccines before acute SARS-CoV-2 infection (vaccine-infection-long-COVID design). Overall, vaccination was associated with reduced risks or odds of long-COVID, with preliminary evidence suggesting that two doses are more effective than one dose. Eleven studies ( n =36,736 COVID-19 survivors) investigated changes in long-COVID symptoms after vaccination (infection-long-COVID-vaccine design). Seven articles showed an improvement in long-COVID symptoms at least one dose post-vaccination, while four studies reported no change or worsening in long-COVID symptoms after vaccination. Interpretation Low level of evidence (grade III, case-controls, cohort studies) suggests that vaccination before SARS-CoV-2 infection could reduce the risk of subsequent long-COVID. The impact of vaccination in people with existing long-COVID symptoms is still controversial, with some data showing changes in symptoms and others did not. These assumptions are limited to those vaccines used in the studies. Funding The LONG-COVID-EXP-CM study supported by a grant of Comunidad de Madrid.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons Attribution (licence family recorded by the source; version not supplied in metadata).
Uniform Resource Identifier <a href="https://europepmc.org/articles/PMC9417563">https://europepmc.org/articles/PMC9417563</a>
546 ## - LANGUAGE NOTE
Language note In English.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Description generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 ## - LOCAL NOTE (RLIN)
Local note Course allocation: B. Sc. Public Health.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vaccine
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sars-cov-2
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Post-covid Syndrome
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Long-covid Symptoms
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term B. Sc. Public Health
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term UMUN open access collection
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term vaccination
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Journal articles.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Jesus Alfonso Catahay
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Jacqueline Veronica Velasco
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Adriel Pastrana
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Abbygail Therese Ver
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Flos Carmeli Pangilinan
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Princess Juneire Peligro
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Michael Casimiro
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Jonathan Jaime Guerrero
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Ma Margarita Leticia Gellaco
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Giuseppe Lippi
Relator term author.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Brandon Michael Henry
Relator term author.
773 0# - HOST ITEM ENTRY
Title EClinicalMedicine
Related parts Vol. 53, (2022), pages/article 101624
International Standard Serial Number 2589-5370
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://europepmc.org/articles/PMC9417563">https://europepmc.org/articles/PMC9417563</a>
Link text Read open-access publication
Public note Open access.
Access status 0
884 ## - DESCRIPTION CONVERSION INFORMATION
Conversion process Course selection and automated MARC21 enrichment from Europe PMC metadata.
Conversion date 20261005
Identifier of source metadata https://europepmc.org/articles/PMC9417563
Conversion agency local
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC No

No items available.